NCT00087776 2025-07-23
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma
American Regent, Inc.
Phase 3 Terminated
American Regent, Inc.
Provectus Pharmaceuticals
Fondazione Michelangelo
AB Science
French Innovative Leukemia Organisation
SWOG Cancer Research Network